congress communication

• DESARROLLO Y OPTIMIZACIÓN DE UN INHIBIDOR PEPTÍDICO PARA EL TRATAMIENTO PREVENTIVO DE LA DIABETES TIPO 1 2023
• DEUCRAVACITINIB, UN INHIBIDOR DEL DOMINIO PSEUDOQUINASA DE LA TIROSINA QUINASA 2 (TYK2), PROTEGE A LAS CÉLULAS BETA HUMANAS FRENTE A AGRESIONES PROINFLAMATORIAS 2023
• IFN¿ exposure affects Ca2+ signaling and hormone secretion in pancreatic alpha- and beta-cells 2023
• Small-molecule inhibitors of protein-protein interaction between TYK2 and IFNAR1 as a new strategy to prevent inflammation in early type 1 diabetes 2023
• Small-molecule inhibitors of protein-protein interaction between TYK2 and IFNAR1 as a new strategy to prevent inflammation in early type 1 diabetes 2023